Canada: The Canadian Special Access Program For Medical Devices

Last Updated: July 15 2013
Article by Lydia Wakulowsky and Ratika Gandhi

Health Canada regulates the safety, efficacy and quality of therapeutic products, including medical devices under the Food and Drugs Act. Before a medical device receives market authorization from Health Canada, access is usually limited to investigational testing involving human subjects, which is sponsored by a manufacturer and authorized by Health Canada through an investigational testing application. When an unlicensed medical device is not available in Canada through enrolment in investigational testing, Health Canada may authorize a health care professional's access to the device through its Special Access Program. This bulletin describes Canada's Special Access Program for medical devices, which is governed by Part 2 of the Medical Devices Regulations made under the Food and Drugs Act.

The Program

Class III or IV custom-made devices and Class II, III or IV medical devices that have not been approved for use in Canada require special access authorization from the Medical Devices Bureau of Health Canada before being imported or sold in Canada. A "custom-made device" is "a medical device, other than a mass-produced medical device, that: (a) is manufactured in accordance with a health care professional's written direction giving its design characteristics; (b) differs from medical devices generally available for sale or from a dispenser; and (c) is (i) for the sole use of a particular patient of that professional, or (ii) for use by that professional to meet special needs arising in the course of his or her practice". Special access authorization is not required for the importation and sale of Class I and II custom-made devices; however, the special access labelling requirements must still be observed.

Canada's Special Access Program allows health care professionals to gain access to Class III or IV custom-made devices and Class II, III or IV medical devices that have not been approved for use in Canada on a narrow and discretionary basis. Health care professionals may access such devices for emergency use or if conventional therapies have failed, are unavailable, or are unsuitable to provide a diagnosis, treatment or prevention for patients under their care. "Health care professional" is defined as "a person who is entitled under the laws of a province to provide health services in the province". This broad definition enables a wide scope professionals to request a medical device for special access − not just physicians.

Application For Authorization

A health care professional is responsible for submitting a complete application for authorization to Health Canada under the Special Access Program. The information to be submitted includes, among other things:

  • information about the device and its manufacturer or importer,
  • the medical rationale for the use of the device, including:

    • the diagnosis, treatment or prevention for which the unlicensed device is required,
    • a list of the licensed devices available for sale in Canada that were considered and a rationale as to why they would not adequately meet the requirements of the patient,
    • the reasons the unlicensed device was chosen for the diagnosis, treatment or prevention,
    • the risks and benefits associated with the use of the unlicensed device,
    • the known safety and effectiveness information in respect of the device, and
    • in the case of a request for a batch release, a description of the emergency condition requiring treatment, and the number of devices required for one month (a batch release authorization can be issued for a one-month supply to devices to treat patients on an urgent basis if shipping delays would result in adverse patient outcomes),
  • the name and address of each health care facility at which the device is to be used by the health care professional and to which the device is to be shipped, and
  • a written undertaking by the health care professional that the professional will inform the patient for whom the device is intended of the risks and benefits associated with its use.

While Health Canada's regulatory authority under the Special Access Program is discretionary Health Canada must issue an authorization to a manufacturer or importer if it determines that:

  • the benefits that may be obtained by the patient through the use of the device outweigh the risks associated with its use,
  • the health or safety of patients, users or other persons will not be unduly affected,
  • a licensed device that would adequately meet the requirements of the patient is not available in Canada, and
  • the authorization is not being used by the manufacturer or importer to circumvent the requirements of Part 1 of the Medical Devices Regulations.

Health Canada provides a decision within three working days for non-emergency requests, and the same day for emergency requests. Health Canada also has the discretion to cancel an authorization after it has been issued.

Issues For Consideration

In considering the special access request, Health Canada does not conduct a comprehensive evaluation on the validity of medical device information or assertions from the manufacturer with respect to safety, efficacy and quality. Therefore, the authorization given for any medical device does not constitute an opinion that it is safe or efficacious. Health care professionals must ensure their decision to recommend the unlicensed medical device is made after an appropriate risk/benefit analysis in the best interests of the patient and is supported by credible evidence found in the medical literature or provided by the manufacturer. Further, as is the case for any treatment, the health care professional must obtain the patient's informed consent to the use of the medical device.

A health care professional must within 72 hours after the occurrence of any incident that comes to his or her attention occurring inside Canada and involving a medical device for which a special access authorization has been issued and that:

  • is related to a failure of the device or a deterioration in its effectiveness, or any inadequacy in its labelling or in the directions for use, and
  • has led to the death or a serious deterioration in the state of health of a patient, user or other person, or could do so were it to recur,

report the incident to Health Canada and to the manufacturer or importer of the device, and specify the nature of the incident and the circumstances surrounding it.

This mandatory problem reporting requirement applies to incidents occurring outside Canada if the manufacturer has indicated, to a regulatory agency of the country in which the incident occurred, the manufacturer's intention to take corrective action, or if the regulatory agency has required the manufacturer to take corrective action.

A manufacturer or importer must ensure the unlicensed device is labelled with the name of the device and manufacturer, and whether the device is custom-made or imported or sold for special access, and maintain a distribution record for the device in accordance with sections 52 through 56 of the Medical Device Regulations. The implant registration requirements of sections 66 to 68 of the Medical Devices Regulations apply in respect of an implant that is imported or sold for special access.

The Special Access Program is responsible only for permitting the import and sale of a medical device to a health care professional. Funding for the delivery of health care is under provincial jurisdiction. Patients will need to determine if the costs of the medical device will be funded by the province, by a private insurer or by the patients themselves.

Health Canada has stated that the Special Access Program is not intended to promote the early use of medical devices and should not be used to circumvent the regulatory review and authorization process for new medical devices in Canada. Because only health care professionals can initiate access requests, it cannot and should not be used by manufacturers or importers to achieve this result.

A manufacturer or importer that advises health care professionals that its medical devices are available by special access may be exposing itself to regulatory action by Health Canada. The Food and Drugs Act provides that no person shall advertise any medical device in a manner that is false, misleading or deceptive or is likely to create an erroneous impression regarding the medical device's design, construction, performance, intended use, quantity, character, value, composition, merit or safety. A Class II, III or IV medical device cannot be advertised for the purpose of sale before the medical device has been licensed by Health Canada. An exception to this advertising prohibition is available if the advertisement is placed only in a catalogue accompanied by a clear and visible warning that the advertised medical device may not have been licensed in accordance with Canadian law.

Manufacturers and importers might be tempted to view the Special Access Program as a means to market unlicensed medical devices in Canada. Given the strict conditions of the Special Access Program that must be fulfilled before access is authorized, it is not a viable way to circumvent the regulatory review and approval process. However, in situations where health care professionals believe that access to these unlicensed medical devices is beneficial, the Special Access Program could potentially provide promising alternatives for patients who may otherwise be precluded from benefitting from certain devices.

The foregoing provides only an overview. Readers are cautioned against making any decisions based on this material alone. Rather, a qualified lawyer should be consulted.

© Copyright 2013 McMillan LLP

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Lydia Wakulowsky
Ratika Gandhi
Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions